B2B: Bladder Cancer Summary

P. Black, A. Kamat, Angela B Smith, S. Porten, R. Eapen, C. Mir, J. Teoh, T. Todenhöfer, Tian Zhang, K. Gust, S. Sridhar, S. Tanguay
{"title":"B2B: Bladder Cancer Summary","authors":"P. Black, A. Kamat, Angela B Smith, S. Porten, R. Eapen, C. Mir, J. Teoh, T. Todenhöfer, Tian Zhang, K. Gust, S. Sridhar, S. Tanguay","doi":"10.48083/NJCD1236","DOIUrl":null,"url":null,"abstract":"The Bench-to-Bedside Uro-Oncology GU Cancer Triad Meeting was organized by the Société Internationale d’Urologie and was held online on May 21st and 22nd, 2021. The session on bladder cancer (BCa) took place on the morning of Friday, May 21st, and was chaired by Dr. Peter C. Black (Canada) and Dr. Ashish Kamat (United States). This session covered practice-changing advances on the horizon for BCa, the use of urine markers in BCa management, evolving therapies for non-muscle-invasive BCa (NMIBC), and recent advances for systemic therapy for muscle-invasive BCa (MIBC) and advanced urothelial carcinoma","PeriodicalId":103607,"journal":{"name":"Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting May 21–22, 2021","volume":"231 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting May 21–22, 2021","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48083/NJCD1236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The Bench-to-Bedside Uro-Oncology GU Cancer Triad Meeting was organized by the Société Internationale d’Urologie and was held online on May 21st and 22nd, 2021. The session on bladder cancer (BCa) took place on the morning of Friday, May 21st, and was chaired by Dr. Peter C. Black (Canada) and Dr. Ashish Kamat (United States). This session covered practice-changing advances on the horizon for BCa, the use of urine markers in BCa management, evolving therapies for non-muscle-invasive BCa (NMIBC), and recent advances for systemic therapy for muscle-invasive BCa (MIBC) and advanced urothelial carcinoma
B2B:膀胱癌总结
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信